* West Pharmaceutical Services Inc WST.N reported
quarterly
adjusted earnings of $1.85 per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of $2.16. The mean expectation of
ten analysts for the quarter was for earnings of $1.50 per
share. Wall Street expected results to range from $1.46
to $1.57 per share.
* Revenue fell 0.1% to $746.90 million from a year ago;
analysts
expected $709.62 million.
* West Pharmaceutical Services Inc's reported EPS for the
quarter
was $1.85.
* The company reported quarterly net income of $136 million.
* West Pharmaceutical Services Inc shares had fallen by 4.6%
this
quarter and lost 18.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 19%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for West
Pharmaceutical Services Inc is $345.00
This summary was machine generated from LSEG data October 24 at
04:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 1.50 1.85 Beat
Jun. 30 2024 1.74 1.52 Missed
Mar. 31 2024 1.27 1.56 Beat
Dec. 31 2023 1.78 1.83 Beat